Purvesh Kalbaile’s Post

Hii Everyone, I'm Happy To Share That I've Obtained A New Certification: Participation In The 40th SPSR International Webinar On 'Adopting Genome Editing Technology In Combating Cancer Disease' Webinar Hosted By Society Of Pharmaceutical Sciences And Reasearch (SPSR) On February 19th 2024. Society of Pharmaceutical Sciences and Research & Managing Editor IJPSR ~Mrs. Monika Sabharwal #goals #spsr #research #science #cancerresearch #pharmaceuticalsciences The more you attend the webinar, the closer you get to your goals.

To all my Pharma colleagues. Check out this Webinar linked below sponsored by Avalere Health!! @Avalere Health is sponsoring @FirstWord Pharma Drugs That Will Shape 2024 webinar, on January 17 2024. Sign up for the webinar and find out about the obesity, gene editing, Alzheimer’s, and oncology drugs that will make an impact in 2024. Sign up now: https://lnkd.in/gQMVmKYa #AvalereHealth #Pharma2024 #AvalereHealthTrends

Thoughts on this? >> Lexeo brings in $95M; FDA lifts hold on Nurix cancer trial >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #productmarketing #pharmaceutical

New Whitepaper - The pharmaceutical industry’s development of innovative therapies over recent years has been astounding. By modifying genetic material in patients with certain hereditary disorders, these have offered the potential to treat conditions such as cancer, heart disease, diabetes and haemophilia. This free whitepaper from Cygnus Technologies, LLC explores the emergence of host-cell protein (HCP) analytics as a critical weapon in biomanufacturers’ arsenals, helping to ensure trailblazing drugs are as safe and effective as possible. Fill in your details to find out more. Click here to download - https://lnkd.in/dTzUENRr #pharma #hostcell #proteinanalytics #clinicaltrials #drugdevelopment

https://buff.ly/3VsgMLb 𝐅𝐃𝐀'𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐖𝐚𝐫𝐩 𝐒𝐩𝐞𝐞𝐝 2.0: 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐑𝐚𝐫𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 🚀🔬 💠 The FDA is taking a page from Operation Warp Speed with its new pilot program, START, designed to accelerate the development of rare disease therapies. This initiative brings together the FDA and seven leading biotech companies to streamline the approval process and bring much-needed treatments to patients faster. 💠 By fostering close collaboration between regulators and drug developers, START aims to optimize clinical trial design, refine patient selection, and enhance communication throughout the development process. 💠 Companies like Denali Therapeutics, Larimar Therapeutics, Grace Science, Neurogene, and Myrtelle are already participating in the program, working on groundbreaking therapies for a variety of rare conditions. 💠 I see this as a much-needed step in the right direction to help sponsors deal with the difficulties in drug development in this area as a result of small patient populations, lack of established endpoints, and the complexities of patient recruitment and retention. #FDA #RareDisease #Biotech #Innovation #DrugDevelopment #orphandrugs

SARBIOFARM CDMO / CRO specializing in custom development and manufacturing of APIs & intermediates. #CRO #CDMO #CRAm #CustomSynthesis #Pharma #Chemicals #Oncology #Biosimilars #MedicinalChemistry #SarBioFarm #DrugDiscoveryCRO #PharmaResearch #BiotechInnovation #ScientificBreakthroughs #ResearchPartnership #InnovativeMedicine #BioPharmaCollaboration #ClinicalResearchOrganization #DrugDevelopment #ScientificAdvancement

CDMO / CRO specializing in custom development and manufacturing of APIs & intermediates. #CRO #CDMO #CRAm #CustomSynthesis #Pharma #Chemicals #Oncology #Biosimilars #MedicinalChemistry #SarBioFarm #DrugDiscoveryCRO #PharmaResearch #BiotechInnovation #ScientificBreakthroughs #ResearchPartnership #InnovativeMedicine #BioPharmaCollaboration #ClinicalResearchOrganization #DrugDevelopment #ScientificAdvancement

https://lnkd.in/g85QaMX9 Key Insights: • Collaboration between GenEdit and Genentech for the discovery and development of hydrophilic nanoparticles (HNPs) for nucleic acid-based medicines targeting autoimmune diseases Visit MedicoInsights to explore key insights #HealthcareNews #drugs #StayInformed #MedicalNews #drugapproval #HealthTrends #Insights #HealthIndustry #HealthInnovation #genetech #gene #alliance #collaboration #HealthcareAnalytics #NewsUpdate #HealthcareNetworking #pharma #pharmaceuticals #pharmanews #pharmaindustry #pharmainnovation #update #medicoinsights

Avalere Health is sponsoring the upcoming Drugs That Will Shape 2024 webinar with FirstWord Pharma on January 17, 2024. Join us to learn about the pharma landscape in the coming year, with key topics including obesity drugs, gene editing, Alzheimer’s, and oncology. Sign up now: https://lnkd.in/gAQNj2mC #AvalereHealth #Pharma2024 #AvalereHealthTrends

CDMO / CRO specializing in custom development and manufacturing of APIs & intermediates. #CRO #CDMO #CRAm #CustomSynthesis #Pharma #Chemicals #Oncology #Biosimilars #MedicinalChemistry #SarBioFarm #DrugDiscoveryCRO #PharmaResearch #BiotechInnovation #ScientificBreakthroughs #ResearchPartnership #InnovativeMedicine #BioPharmaCollaboration #ClinicalResearchOrganization #DrugDevelopment